unknown
Stage
About
ConveloTx develops patented remyelination-enhancing therapies targeting the central nervous system to promote repair and regeneration for multiple sclerosis patients.
Explore ConveloTx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.